SCM Lifescience Co., Ltd. (KOSDAQ:298060)
South Korea flag South Korea · Delayed Price · Currency is KRW
807.00
+19.00 (2.41%)
At close: Apr 3, 2026

SCM Lifescience Revenue

SCM Lifescience had revenue of 638.80M KRW in the quarter ending June 30, 2025, with 139.55% growth. This brings the company's revenue in the last twelve months to 1.54B, up 53.75% year-over-year. In the year 2024, SCM Lifescience had annual revenue of 824.80M with 18.56% growth.

Revenue (ttm)
1.54B
Revenue Growth
+53.75%
P/S Ratio
23.12
Revenue / Employee
n/a
Employees
n/a
Market Cap
35.67B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024824.80M129.10M18.56%
Dec 31, 2023695.70M299.72M75.69%
Dec 31, 2022395.98M-43.28M-9.85%
Dec 31, 2021439.26M119.26M37.27%
Dec 31, 2020320.01M151.51M89.92%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
J2KBIO32.97B
NGeneBio21.24B
ADBiotech12.90B
MOA Life Plus11.22B
Eutilex.Co.,Ltd10.54B
SunBio,Inc.2.17B
Kainos Medicine1.17B
Epibiotech449.62M
Revenue Rankings